Without using animals: antibodies from algae for pregnancy tests

Start-up develops new process - DBU provides funding

19-Nov-2024 - It is not every day that young start-ups from Germany launch an innovation with industry-changing potential onto the market. But this is exactly what Phaeosynt, a company founded out of the University of Hanover, is planning to do with its diatom-derived antibodies for medical diagnostics. Until ...

Mainz Biomed and Thermo Fisher Scientific sign collaboration agreement

Development of next-generation colorectal cancer screening product for global markets

14-Nov-2024 - Mainz Biomed N.V. announced a collaborative agreement with Thermo Fisher Scientific Inc. (NYSE: TMO), through its subsidiary Life Technologies Corporation (“Thermo Fisher”), a world leader in supplying life sciences solutions and services. The collaboration agreement will enable Mainz Biomed and ...

Aignostics secures $34 million Series B to improve precision medicine with AI

Investments will support new product offerings, US expansion, and development of pathology foundation models

05-Nov-2024 - Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced that it has raised $34 million in Series B financing. This additional funding will be used to build new product offerings for biopharmaceutical clients, ...

Eurofins agrees to acquire SYNLAB’s clinical diagnostics operations in Spain

30-Oct-2024 - Eurofins Scientific has reached an agreement with SYNLAB to acquire its clinical diagnostics operations in Spain. The transaction is subject to customary conditions, including regulatory approvals, and is expected to close in 2025. SYNLAB’s clinical diagnostics operations in Spain provide ...

AI in medicine: new approach for more efficient diagnostics

Researchers have developed a new AI tool that uses imaging data to also detect less frequent diseases of the gastrointestinal tract

28-Oct-2024 - Already used in many areas of medicine, AI has tremendous potential when it comes to helping doctors diagnose diseases with the help of imaging data. However, AI models have to be trained with large numbers of examples, which are generally available in sufficient quantities only for common ...

AI helps to detect antibiotic resistance

This is an important first step toward integrating GPT-4 into clinical diagnostics

24-Oct-2024 - Researchers at the University of Zurich (UZH) have used artificial intelligence (AI) to help identify antibiotic-resistant bacteria. The team led by Adrian Egli, UZH professor at the Institute of Medical Microbiology, is the first to investigate how GPT-4, a powerful AI model developed by OpenAI, ...

New test improves diagnosis of allergies

Higher diagnostic accuracy than standard tests

21-Oct-2024 - Researchers at the University of Bern and Bern University Hospital have developed a test to simplify the diagnosis of allergies. Its effectiveness has now been confirmed in clinical samples from children and adolescents suffering from a peanut allergy. The results could fundamentally improve the ...

Light on – light off: the test result is ready

Inspired by nature - Light-controlled bio-based OptoAssays can diagnose diseases more easily and cost-effectively

30-Sep-2024 - From Velcro to solar cells, many technological innovations have been inspired by nature. In medical diagnostics, researchers also draw inspiration from biological principles. A research team from the University of Freiburg and the INM – Leibniz Institute for New Materials in Saarbrücken has ...

€1.3M pre-seed funding for Lucid Genomics

Startup will use funds to fine-tune their AI models for diagnostics and biomarker discovery

05-Sep-2024 - The Berlin-based startup Lucid Genomics, a spin-off from the Max Planck Institute for Molecular Genetics and the Institute of Medical Genetics and Human Genetics at the Charité - Universitätsmedizin Berlin, has raised €1.3 million in pre-seed funding in a funding round led by Caesar Ventures, ...

Artificial intelligence improves lung cancer diagnosis

New AI-based digital platform enables extremely fast and accurate analysis of tissue sections from lung cancer patients

27-Aug-2024 - A team of researchers from the University of Cologne’s Faculty of Medicine and University Hospital Cologne, led by Dr Yuri Tolkach and Professor Dr Reinhard Büttner, has created a digital pathology platform based on artificial intelligence. The platform uses new algorithms developed by the team ...